REPORT ID 6255

EMEA (Europe, Middle East and Africa) Human Papillomavirus Protein E6 Market Report 2017

Publish Date
25-Dec-17
Pages
118
Format
Electronic (PDF)

In this report, the EMEA Human Papillomavirus Protein E6 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Human Papillomavirus Protein E6 for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Human Papillomavirus Protein E6 market competition by top manufacturers/players, with Human Papillomavirus Protein E6 sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Rottapharm Biotech Srl
    Selecta Biosciences Inc
    Transgene SA
    Abion Inc
    BioNTech AG
    Cancer Research Technology Ltd
    Etubics Corp
    Genexine Inc
    Hookipa Biotech AG
    Inovio Pharmaceuticals Inc
    MedImmune LLC

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    ABN-301
    BVAC-C
    ETBX-041
    GX-188E
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Cervical Intraepithelial Neoplasia
    Lung Cancer
    Oropharyngeal Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Human Papillomavirus Protein E6 Market Report 2017
1 Human Papillomavirus Protein E6 Overview
    1.1 Product Overview and Scope of Human Papillomavirus Protein E6
    1.2 Classification of Human Papillomavirus Protein E6
        1.2.1 EMEA Human Papillomavirus Protein E6 Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Human Papillomavirus Protein E6 Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 ABN-301
        1.2.4 BVAC-C
        1.2.5 ETBX-041
        1.2.6 GX-188E
        1.2.7 Others
    1.3 EMEA Human Papillomavirus Protein E6 Market by Application/End Users
        1.3.1 EMEA Human Papillomavirus Protein E6 Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Cervical Intraepithelial Neoplasia
        1.3.3 Lung Cancer
        1.3.4 Oropharyngeal Cancer
        1.3.5 Others
    1.4 EMEA Human Papillomavirus Protein E6 Market by Region
        1.4.1 EMEA Human Papillomavirus Protein E6 Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Human Papillomavirus Protein E6 (2012-2022)
        1.5.1 EMEA Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Human Papillomavirus Protein E6 Revenue and Growth Rate (2012-2022)

2 EMEA Human Papillomavirus Protein E6 Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Human Papillomavirus Protein E6 Market Competition by Players/Manufacturers
        2.1.1 EMEA Human Papillomavirus Protein E6 Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Human Papillomavirus Protein E6 Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Human Papillomavirus Protein E6 Sale Price by Players (2012-2017)
    2.2 EMEA Human Papillomavirus Protein E6 (Volume and Value) by Type/Product Category
        2.2.1 EMEA Human Papillomavirus Protein E6 Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Human Papillomavirus Protein E6 Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Human Papillomavirus Protein E6 Sale Price by Type (2012-2017)
    2.3 EMEA Human Papillomavirus Protein E6 (Volume) by Application
    2.4 EMEA Human Papillomavirus Protein E6 (Volume and Value) by Region
        2.4.1 EMEA Human Papillomavirus Protein E6 Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Human Papillomavirus Protein E6 Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Human Papillomavirus Protein E6 Sales Price by Region (2012-2017)

3 Europe Human Papillomavirus Protein E6 (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Human Papillomavirus Protein E6 Sales and Value (2012-2017)
        3.1.1 Europe Human Papillomavirus Protein E6 Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Human Papillomavirus Protein E6 Revenue and Growth Rate (2012-2017)
    3.2 Europe Human Papillomavirus Protein E6 Sales and Market Share by Type
    3.3 Europe Human Papillomavirus Protein E6 Sales and Market Share by Application
    3.4 Europe Human Papillomavirus Protein E6 Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Human Papillomavirus Protein E6 Sales Volume by Countries (2012-2017)
        3.4.2 Europe Human Papillomavirus Protein E6 Revenue by Countries (2012-2017)
        3.4.3 Germany Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2017)
        3.4.4 France Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2017)
        3.4.5 UK Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2017)
        3.4.6 Russia Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2017)
        3.4.7 Italy Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2017)

4 Middle East Human Papillomavirus Protein E6 (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Human Papillomavirus Protein E6 Sales and Value (2012-2017)
        4.1.1 Middle East Human Papillomavirus Protein E6 Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Human Papillomavirus Protein E6 Revenue and Growth Rate (2012-2017)
    4.2 Middle East Human Papillomavirus Protein E6 Sales and Market Share by Type
    4.3 Middle East Human Papillomavirus Protein E6 Sales and Market Share by Application
    4.4 Middle East Human Papillomavirus Protein E6 Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Human Papillomavirus Protein E6 Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Human Papillomavirus Protein E6 Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2017)
        4.4.4 Israel Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2017)
        4.4.5 UAE Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2017)
        4.4.6 Iran Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2017)

5 Africa Human Papillomavirus Protein E6 (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Human Papillomavirus Protein E6 Sales and Value (2012-2017)
        5.1.1 Africa Human Papillomavirus Protein E6 Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Human Papillomavirus Protein E6 Revenue and Growth Rate (2012-2017)
    5.2 Africa Human Papillomavirus Protein E6 Sales and Market Share by Type
    5.3 Africa Human Papillomavirus Protein E6 Sales and Market Share by Application
    5.4 Africa Human Papillomavirus Protein E6 Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Human Papillomavirus Protein E6 Sales Volume by Countries (2012-2017)
        5.4.2 Africa Human Papillomavirus Protein E6 Revenue by Countries (2012-2017)
        5.4.3 South Africa Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Human Papillomavirus Protein E6 Sales and Growth Rate (2012-2017)

6 EMEA Human Papillomavirus Protein E6 Manufacturers/Players Profiles and Sales Data
    6.1 Rottapharm Biotech Srl
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Human Papillomavirus Protein E6 Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Rottapharm Biotech Srl Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Selecta Biosciences Inc
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Human Papillomavirus Protein E6 Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Selecta Biosciences Inc Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Transgene SA
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Human Papillomavirus Protein E6 Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Transgene SA Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Abion Inc
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Human Papillomavirus Protein E6 Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Abion Inc Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 BioNTech AG
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Human Papillomavirus Protein E6 Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 BioNTech AG Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Cancer Research Technology Ltd
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Human Papillomavirus Protein E6 Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Cancer Research Technology Ltd Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Etubics Corp
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Human Papillomavirus Protein E6 Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Etubics Corp Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Genexine Inc
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Human Papillomavirus Protein E6 Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Genexine Inc Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Hookipa Biotech AG
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Human Papillomavirus Protein E6 Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Hookipa Biotech AG Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Inovio Pharmaceuticals Inc
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Human Papillomavirus Protein E6 Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Inovio Pharmaceuticals Inc Human Papillomavirus Protein E6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 MedImmune LLC

7 Human Papillomavirus Protein E6 Manufacturing Cost Analysis
    7.1 Human Papillomavirus Protein E6 Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Human Papillomavirus Protein E6

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Human Papillomavirus Protein E6 Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Human Papillomavirus Protein E6 Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Human Papillomavirus Protein E6 Market Forecast (2017-2022)
    11.1 EMEA Human Papillomavirus Protein E6 Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Human Papillomavirus Protein E6 Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Human Papillomavirus Protein E6 Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Human Papillomavirus Protein E6 Price and Trend Forecast (2017-2022)
    11.2 EMEA Human Papillomavirus Protein E6 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Human Papillomavirus Protein E6 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Human Papillomavirus Protein E6 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Human Papillomavirus Protein E6 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Human Papillomavirus Protein E6 Sales Forecast by Type (2017-2022)
    11.7 EMEA Human Papillomavirus Protein E6 Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer